Skip to content

A study on the assessment of diagnostic and therapeutic efficacy using contrast-enhanced FDG-PET/CT for cardiac sarcoidosis

Prospective study on the assessment of diagnostic and therapeutic efficacy of FDG-PET/CT with delayed contrast-enhanced CT on cardiac sarcoidosis - The assessment of diagnostic efficacy of PET/CT with delayed contrast-enhanced CT for cardiac sarcoidosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000046704
Enrollment
50
Registered
2022-01-25
Start date
2022-01-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac sarcoidosis

Interventions

Delayed contrast enhanced CT of myocardium

Sponsors

Ehime university
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Patients for whom written consent has been obtained from the individual (2) Patients who can be hospitalized and attend outpatient clinics

Exclusion criteria

Exclusion criteria: 1) Patients who have not been fasting for a long time (more than 18 hours) 2) Patients with renal failure(eGFR <30) 3) Patients with hyperthyroidism 4) Patients who are pregnant or of childbearing potential 5) Patients with allergy to contrast material 6) Patients with bronchial asthma 7) Patients who are judged unsuitable for participation in this study by the investigator for other reasons (8) Patients with poorly controlled diabetes mellitus

Design outcomes

Primary

MeasureTime frame
Diagnostic performance of late iodine enhancement of myocardium using contrast-enhanced PET/CT

Secondary

MeasureTime frame
Determination of efficacy after steroid treatment in areas of active inflammation (FDG accumulation) and myocardial fibrosis (delayed enhancement)

Countries

Japan

Contacts

Public ContactKawaguchi Naoto

Ehime University Graduate School of Medicine Department of Radiology

n.kawa1113@gmail.com089-960-5371

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026